| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |